RAMM Pharma Corp. Stock

RAMM

CA75150G1046

Pharmaceuticals

Market Closed - Canadian Securities Exchange 16:30:00 16/09/2026 +03			5-day change	1st Jan Change
0.0100 ^CAD	+100.00%		+100.00%	-83.33%

06-30	RAMM Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI
04-02	RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026	CI

Latest news: RAMM Pharma Corp.

06-30	RAMM Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI
04-02	RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026	CI
03-05	RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2025	CI
03-05	RAMM Pharma Corp. Auditor Raises 'Going Concern' Doubt	CI
27/09/25	RAMM Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2025	CI
28/06/25	RAMM Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2025	CI
30/05/25	Jack Burnett of RAMM Pharma Corp. acquired additional 3.91% stake in RAMM Pharma Corp. from Armando Blankleider for CAD 46.6 million.	CI
01/04/25	RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2025	CI
04/03/25	Tranche Update on RAMM Pharma Corp.'s Equity Buyback Plan announced on September 5, 2023.	CI
04/03/25	RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2024	CI
04/03/25	RAMM Pharma Corp. Auditor Raises 'Going Concern' Doubt	CI
22/01/25	RAMM Pharma Explores Sale of its Canapar Unit	MT
28/09/24	Tranche Update on RAMM Pharma Corp.'s Equity Buyback Plan announced on September 5, 2023.	CI

More news

Press Releases: RAMM Pharma Corp.

11-14	RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.	GL
11-07	RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders	GL
23/10/25	RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials	GL
31/05/25	Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.	AQ
22/01/25	RAMM Pharma Corp. Provides Update on Canapar	GL

More press releases

Managers and Directors: RAMM Pharma Corp.

Manager	Title	Age	Since
Jackie Burnett CEO	Chief Executive Officer	-	01/10/2019
José Roldan DFI	Director of Finance/CFO	-	09/12/2022

Director	Title	Age	Since
Jackie Burnett BRD	Director/Board Member	-	01/10/2019
Daniel Augereau BRD	Director/Board Member	82	01/10/2019
Eric Klein BRD	Director/Board Member	66	01/10/2019

More insiders

RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
16/09/26	CA$0.0100	+100.00%	50,000

Delayed Quote Canadian Securities Exchange

More quotes

Market Cap	1.19M 851K 742K 699K 637K 81.57M 1.2M 8.37M 3.23M 41.55M 3.2M 3.13M 134M	P/E 2024	-0.07x	P/E 2025	-0.2x
Enterprise Value	470K 335K 293K 275K 251K 32.14M 471K 3.3M 1.27M 16.37M 1.26M 1.23M 52.83M	EV / Sales 2024	0.13x	EV / Sales 2025	0.32x
Free-Float	68.57%	Yield 2024 *	-	Yield 2025	-

1 day	+100.00%
1 week	+100.00%
Current month	+100.00%
3 months	-33.33%
6 months	-33.33%
Current year	-83.33%

1 week	0.01	0.01
1 month	0	0.01
Current year	0	0.05
1 year	0	0.25
3 years	0	0.25
5 years	0	0.6
10 years	0	1.19

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/2/25 A	Jackie Burnett	Sell	Chief Executive Officer	4,667,000	3.9091%
3/21/25 A	Jackie Burnett	Buy	Chief Executive Officer	200,000	0.1675%
3/21/25 A	Jackie Burnett	Buy	Chief Executive Officer	100,000	0.0838%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RAMM PHARMA CORP.	+100.00%	+100.00%	-33.33%	-90.00%	852K
ELI LILLY AND COMPANY	+1.04%	+2.34%	+54.30%	+111.75%	1,028B
JOHNSON & JOHNSON	-0.19%	+1.18%	+54.68%	+66.69%	651B
ABBVIE INC.	+0.20%	+1.04%	+18.82%	+72.38%	466B
ROCHE HOLDING AG	+2.24%	+5.98%	+37.61%	+42.44%	346B
NOVARTIS AG	+0.90%	+3.66%	+18.79%	+25.03%	266B
ASTRAZENECA PLC	+0.48%	+7.28%	+11.11%	+14.70%	259B
AMGEN INC.	+1.95%	+3.06%	+37.47%	+45.93%	208B
NOVO NORDISK A/S	-7.65%	-5.95%	-33.09%	-60.76%	191B
GILEAD SCIENCES, INC.	+0.30%	+2.83%	+33.84%	+100.03%	186B
Average	+9.97%	+2.93%	+20.02%	+32.82%	360.17B
Weighted average by Cap.	+0.34%	+3.09%	+35.77%	+64.90%

RAMM Pharma Corp. Stock

Stocks

RAMM

CA75150G1046

Pharmaceuticals

Valuation: RAMM Pharma Corp.

Chart: RAMM Pharma Corp.

Latest news: RAMM Pharma Corp.

Press Releases: RAMM Pharma Corp.

Quotes and Performance

Price Extremes

Managers and Directors: RAMM Pharma Corp.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

	2024	2025
Net sales	4.34M 3.1M 2.7M 2.54M 2.32M 297M 4.35M 30.45M 11.74M 151M 11.63M 11.37M 488M	3.36M 2.4M 2.09M 1.97M 1.79M 230M 3.36M 23.57M 9.08M 117M 9M 8.8M 377M
Net income	-16.5M -11.77M -10.26M -9.66M -8.8M -1.13B -16.52M -116M -44.61M -574M -44.21M -43.23M -1.85B	-8.91M -6.35M -5.54M -5.22M -4.75M -609M -8.92M -62.49M -24.09M -310M -23.87M -23.34M -1B
Net Debt	-626K -446K -389K -366K -334K -42.75M -627K -4.39M -1.69M -21.78M -1.68M -1.64M -70.28M	-723K -516K -450K -424K -386K -49.43M -724K -5.07M -1.96M -25.18M -1.94M -1.9M -81.26M